Article
Characterizing multi-PIK3CA mutations across cancer types: Toward precision oncology.
Cancer medicine - 1 Jul 2024
Nakamura Kohei, Ishikawa Marin, Kawano Ryutaro, Aimono Eriko, Mizuno Takaaki, Nohara Sachio, Tanishima Shigeki, Hayashi Hideyuki, Nishihara Hiroshi
Abstract excerpt
BACKGROUND: PIK3CA mutations are implicated in various cancers, but the implications of multiple concurrent mutations and their orientations within the gene have not been fully explored. METHODS: In this study, we analyzed multi-PIK3CA mutations across a diverse pan-cancer cohort comprising 3564 tumors. RESULTS: Multi-PIK3CA mutations were present in 10.3% of all PIK3CA-mutant tumors, predominantly occurring in...
Topics
- Humans
- Class I Phosphatidylinositol 3-Kinases
- Mutation
- Neoplasms
- Precision Medicine
- Biomarkers, Tumor
- Female
